Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1627
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18499941 | ANTI-VIRAL COMPOUNDS | Non-Final OA | Katholieke Universiteit Leuven |
| 18539519 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | Non-Final OA | BRISTOL-MYERS SQUIBB COMPANY |
| 18261373 | ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18287427 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS THROUGH INHIBITION OF CD44 AND FERM PROTEIN INTERACTION | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | Non-Final OA | YALE UNIVERSITY |
| 18254936 | STABILIZED COMPOSITIONS CONTAINING STROBILURIN FUNGICIDES AND POLYHYDRIC ALCOHOLS | Non-Final OA | ADAMA MAKHTESHIM LTD. |
| 18172771 | CHEMICAL COMPOSITIONS AND METHODS OF USE | Non-Final OA | Bruker Spatial Biology, Inc. |
| 18422930 | L-ERGOTHIONEINE AND USES THEREOF | Non-Final OA | NANJING NUTRABUILDING BIO-TECH CO., LTD. |
| 18575809 | METHODS FOR TREATMENT OF OPIOID USE DISORDER WITH CANNABINOIDS | Non-Final OA | LYOTROPIC DELIVERY SYSTEMS LTD. |
| 18519269 | Pharmaceutical Mixture Comprising Amorphous Pitolisant | Non-Final OA | Alfred E. Tiefenbacher GmbH & Co. KG |
| 18386985 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER | Non-Final OA | CKP Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy